SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults

European Journal of Endocrinology

Volumn 170, Issue 1, 2014, Pages 101-107

  Glad, Camilla A M ^a   Barbosa, Edna J L ^a,b   Nystrom̈, Helena Filipsson ^a   Carlsson, Lena M S ^a   Nilsson, Staffan ^c   Nilsson, Anna G ^a   Svensson, Per Arne ^a   Johannsson, Gudmundur ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; JANUS KINASE 2; SOMATOMEDIN C; STAT5B PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 2;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENOTYPE; GENOTYPING TECHNIQUE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; JANUS KINASE 2 GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE CATALYTIC SUBUNIT BETA GENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STAT5B GENE; SUPPRESSOR OF CYTOKINE SIGNALING GENE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DRUG MONITORING; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SWEDEN; YOUNG ADULT;

EID: 84890519661     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0685     Document Type: Article

References (30)

1. Johannsson G & Bengtsson BA. Growth hormone and the metabolic syndrome. Journal of Endocrinological Investigation 1999 22 41-46.
2. Rosen T & Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 336 285-288. (doi:10.1016/0140-6736(90) 91812-O)
3. Boguszewski CL, Meister LH, Zaninelli DC & Radominski RB. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. European Journal of Endocrinology 2005 152 67-75. (doi:10.1530/eje.1.01817)
4. Cook DM, Ludlam WH & Cook MB. Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1999 84 3956-3960. (doi:10.1210/jc.84.11.3956)
5. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rosen T, Thoren M & Bengtsson BA. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. Journal of Clinical Endocrinology and Metabolism 1996 81 1575-1581. (doi:10.1210/jc.81.4.1575)
6. Barbosa EJ, Koranyi J, Filipsson H, Bengtsson BA, Boguszewski CL & Johannsson G. Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults. European Journal of Endocrinology 2010 162 869-878. (doi:10.1530/EJE-09-0973)
7. Wassenaar MJ, Dekkers OM, Pereira AM, Wit JM, Smit JW, Biermasz NR & Romijn JA. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2009 94 3721-3730. (doi:10.1210/jc.2009-0425)
8. Adetunji OR, MacFarlane IA, Javadpour M, Alfirevic A, Pirmohamed M & Blair JC. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy. European Journal of Endocrinology 2009 161 541-546. (doi:10.1530/EJE-09-0405)
9. Barbosa EJ, Palming J, Glad CA, Filipsson H, Koranyi J, Bengtsson BA, Carlsson LM, Boguszewski CL & Johannsson G. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency. Journal of Clinical Endocrinology and Metabolism 2009 94 639-644. (doi:10.1210/jc.2008- 0323)
10. Meyer S, Schaefer S, Stolk L, Arp P, Uitterlinden AG, Plockinger U, Stalla GK, Tuschy U, Weber MM, Weise A et al. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults. Pharmacogenomics 2009 10 1599-1608. (doi:10.2217/pgs.09.91)
11. van der Klaauw AA, van der Straaten T, Baak-Pablo R, Biermasz NR, Guchelaar HJ, Pereira AM, Smit JW & Romijn JA. Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 2008 93 2828-2834. (doi:10.1210/jc.2007-2728)
12. Barton DE, Foellmer BE, Wood WI & Francke U. Chromosome mapping of the growth hormone receptor gene in man and mouse. Cytogenetics and Cell Genetics 1989 50 137-141. (doi:10.1159/000132743)
13. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z & Wood WI. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. PNAS 1989 86 8083-8087. (doi:10.1073/pnas. 86.20.8083)
14. Leung KC. Regulation of cytokine receptor signaling by nuclear hormone receptors: a new paradigm for receptor interaction. DNA and Cell Biology 2004 23 463-474. (doi:10.1089/1044549041562285)
15. Zhu T, Goh EL, Graichen R, Ling L & Lobie PE. Signal transduction via the growth hormone receptor. Cellular Signalling 2001 13 599-616. (doi:10.1016/S0898-6568(01)00186-3)
16. Flores-Morales A, Greenhalgh CJ, Norstedt G & Rico-Bautista E. Negative regulation of growth hormone receptor signaling. Molecular Endocrinology 2006 20 241-253. (doi:10.1210/me.2005-0170)
17. Leung KC, Doyle N, Ballesteros M, Sjogren K, Watts CK, Low TH, Leong GM, Ross RJ & Ho KK. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. PNAS 2003 100 1016-1021. (doi:10.1073/pnas.0337600100)
18. Lanning NJ & Carter-Su C. Recent advances in growth hormone signaling. Reviews in Endocrine & Metabolic Disorders 2006 7 225-235. (doi:10.1007/s11154-007-9025-5)
19. Le Stunff C, Dechartres A, Mariot V, Lotton C, Trainor C, Miraglia Del Giudice E, Meyre D, Bieche I, Laurendeau I, Froguel P et al. Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children. Diabetes 2008 57 494-502. (doi:10.2337/db07-1273)
20. Bonafe M, Barbieri M, Marchegiani F, Olivieri F, Ragno E, Giampieri C, Mugianesi E, Centurelli M, Franceschi C & Paolisso G. Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. Journal of Clinical Endocrinology and Metabolism 2003 88 3299-3304. (doi:10.1210/jc.2002-021810)
21. Ge D, Gooljar SB, Kyriakou T, Collins LJ, Swaminathan R, Snieder H, Spector TD & O'Dell SD. Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile. Obesity 2008 16 492-496. (doi:10.1038/oby.2007.79)
22. Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D et al. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. Endocrine-Related Cancer 2007 14 267-277. (doi:10.1677/ERC-06-0077)
23. Makimura M, Ihara K, Kojima-Ishii K, Nozaki T, Ohkubo K, Kohno H, Kishimoto J & Hara T. The signal transducer and activator of transcription 5B gene polymorphism contributes to the cholesterol metabolism in Japanese children withgrowthhormone deficiency. Clinical Endocrinology 2011 74 611-617. (doi:10.1111/j.1365-2265.2011.03980.x)
24. Sovio U, Bennett AJ, Millwood IY, Molitor J, O'Reilly PF, Timpson NJ, Kaakinen M, Laitinen J, Haukka J, Pillas D et al. Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genetics 2009 5 e1000409. (doi:10.1371/journal. pgen.1000409)
25. Weedon MN, Lango H, Lindgren CM, Wallace C, Evans DM, Mangino M, Freathy RM, Perry JR, Stevens S, Hall AS et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nature Genetics 2008 40 575-583. (doi:10.1038/ng.121)
26. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)
27. Johannsson G, Rosen T & Bengtsson BA. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology 1997 47 571-581. (doi:10.1046/j.1365-2265.1997.3271123.x)
28. Glad CA, Johannsson G, Carlsson LM& Svensson PA. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP. Growth Hormone & IGF Research 2010 20 270-273. (doi:10.1016/j.ghir.2010.02.004)
29. Barbosa EJ, Glad CA, Nilsson AG, Filipsson Nyström H, Gotherstrom G, Svensson PA, Vinotti I, Bengtsson BA, Nilsson S, Boguszewski CL et al. Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy. European Journal of Endocrinology 2012 167 353-362. (doi:10.1530/EJE-12-0263)
30. Svensson J, Johannsson G & Bengtsson BA. Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clinical Endocrinology 1997 46 579-586. (doi:10.1046/j.1365-2265.1997.1851001.x)